Literature DB >> 15067308

Emerging infectious diseases.

Vincent R Racaniello1.   

Abstract

Human population growth, technological advances, and changing social behaviors lead to the selection of new microbial pathogens. Antimicrobial drugs, vaccines, diagnostics, and treatments for emerging infectious diseases must be developed. The selective forces that drive the emergence of new infectious diseases, and the implications for our survival, are just beginning to be understood.

Entities:  

Mesh：

Year:  2004        PMID： 15067308      PMCID： PMC362132          DOI： 10.1172/JCI21370

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  5 in total

Review 1.  West Nile virus: a growing concern?

Authors:  L Hannah Gould; Erol Fikrig
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 3.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 4.  Germs, governance, and global public health in the wake of SARS.

Authors:  David P Fidler
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 5.  Acute HIV revisited: new opportunities for treatment and prevention.

Authors:  Christopher D Pilcher; Joseph J Eron; Shannon Galvin; Cynthia Gay; Myron S Cohen
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808
  5 in total
  8 in total

1.  Hantaviruses in the americas and their role as emerging pathogens.

Authors:  Brian Hjelle; Fernando Torres-Pérez
Journal:  Viruses       Date:  2010-11-25       Impact factor: 5.048

2.  Resistance to the crayfish plague, Aphanomyces astaci (Oomycota) in the endangered freshwater crayfish species, Austropotamobius pallipes.

Authors:  Laura Martín-Torrijos; Miquel Campos Llach; Quim Pou-Rovira; Javier Diéguez-Uribeondo
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 3.  [Emergence and species barriers].

Authors:  A Vabret
Journal:  Med Mal Infect       Date:  2004-11       Impact factor: 2.152

4.  Rodent-Human Interface: Behavioral Risk Factors and Leptospirosis in a Province in the Central Region of Thailand.

Authors:  Kanokwan Suwannarong; Ngamphol Soonthornworasiri; Pannamas Maneekan; Surapon Yimsamran; Karnsunaphat Balthip; Santi Maneewatchararangsri; Watcharee Saisongkorh; Chutarat Saengkul; Suntaree Sangmukdanun; Nittaya Phunta; Pratap Singhasivanon
Journal:  Vet Sci       Date:  2022-02-17

Review 5.  Potential repurposed SARS-CoV-2 (COVID-19) infection drugs.

Authors:  Gamal El-Din A Abuo-Rahma; Mamdouh F A Mohamed; Tarek S Ibrahim; Mai E Shoman; Ebtihal Samir; Rehab M Abd El-Baky
Journal:  RSC Adv       Date:  2020-07-17       Impact factor: 4.036

Review 6.  Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Authors:  M A Oke; F J Afolabi; O O Oyeleke; T A Kilani; A R Adeosun; A A Olanbiwoninu; E A Adebayo
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

7.  Genomic surveillance of SARS-COV-2 reveals diverse circulating variant lineages in Nairobi and Kiambu Counties, Kenya.

Authors:  Josiah O Kuja; Bernard N Kanoi; Renzo F Balboa; Clement Shiluli; Michael Maina; Harrison Waweru; Kimita Gathii; Mary Mungai; Moses Masika; Omu Anzala; Matilu Mwau; Taane G Clark; John Waitumbi; Jesse Gitaka
Journal:  BMC Genomics       Date:  2022-09-01       Impact factor: 4.547

Review 8.  Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.

Authors:  Nicholas Israel Nii-Trebi
Journal:  Biomed Res Int       Date:  2017-02-13       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.